Baruch D I, Ma X C, Singh H B, Bi X, Pasloske B L, Howard R J
Affymax Research Institute, Santa Clara, CA, USA.
Blood. 1997 Nov 1;90(9):3766-75.
Adherence of mature parasitized erythrocytes (PE) of Plasmodium falciparum to microvascular endothelial cells contributes directly to the virulence and pathology of this human malaria. The malarial variant antigen, P falciparum erythrocyte membrane protein 1 (PfEMP1), has been implicated as the PE receptor for CD36 on endothelial cells. We identified the region of PfEMP1 that mediates adherence of PE to CD36 and showed that a recombinant protein fragment from this region blocked and reversed adherence of antigenically different parasites. Sequence variation was evident in the CD36 binding domain of different PfEMP1 genes, yet many highly conserved residues, particularly cysteine residues, are evident. This suggests a highly conserved shape that mediates adherence to CD36. Immunization with the CD36-binding domain elicited sera that are cross-reactive with the different recombinant proteins but are strain-specific for the PE surface. Novel anti-adherence therapeutics and a malaria vaccine may derived from exploitation of the structure of the CD36 binding domain of PfEMP1.
恶性疟原虫成熟寄生红细胞(PE)与微血管内皮细胞的黏附直接导致了这种人类疟疾的毒力和病理变化。疟原虫变异抗原,即恶性疟原虫红细胞膜蛋白1(PfEMP1),被认为是内皮细胞上CD36的PE受体。我们确定了PfEMP1介导PE与CD36黏附的区域,并表明来自该区域的重组蛋白片段可阻断并逆转抗原性不同的寄生虫的黏附。不同PfEMP1基因的CD36结合域存在明显的序列变异,但也有许多高度保守的残基,尤其是半胱氨酸残基。这表明存在一种介导与CD36黏附的高度保守的结构。用CD36结合域进行免疫可引发与不同重组蛋白具有交叉反应但对PE表面具有菌株特异性的血清。新型抗黏附疗法和疟疾疫苗可能源于对PfEMP1的CD36结合域结构的利用。